Skip to main content

Prescription Digital Therapeutics Centers of Excellence

Prescription Digital Therapeutics
Excellence Forum
This content is intended for formulary decision makers.

Commentary
01/24/2024
In January 2024, Better Therapeutics, Inc submitted a request to the US Food and Drug Administration (FDA) for Breakthrough Device Designation for its new prescription digital therapeutic (PDT) designed to treat metabolic...
In January 2024, Better Therapeutics, Inc submitted a request to the US Food and Drug Administration (FDA) for Breakthrough Device Designation for its new prescription digital therapeutic (PDT) designed to treat metabolic...
In January 2024, Better...
01/24/2024
First Report Managed Care
Commentary
01/12/2024
In January 2024, Better Therapeutics Inc. and Glooko Inc. announced a partnership to integrate Better Therapeutics’ AspyreRx™ digital behavioral treatment for type 2 diabetes (T2D) into Glooko’s diabetes management platform.
In January 2024, Better Therapeutics Inc. and Glooko Inc. announced a partnership to integrate Better Therapeutics’ AspyreRx™ digital behavioral treatment for type 2 diabetes (T2D) into Glooko’s diabetes management platform.
In January 2024, Better...
01/12/2024
First Report Managed Care
Commentary
12/20/2023
In July 2023, GoodRx announced the launch of a new app known as Medicine Cabinet. In the press release, the company described the novel app as “a comprehensive solution designed to help consumers seamlessly manage their medications. Medicine...
In July 2023, GoodRx announced the launch of a new app known as Medicine Cabinet. In the press release, the company described the novel app as “a comprehensive solution designed to help consumers seamlessly manage their medications. Medicine...
In July 2023, GoodRx announced...
12/20/2023
First Report Managed Care
Commentary
12/14/2023
Prescription digital therapeutics (PDTs) allow patients and prescribers to work collaboratively and to use ongoing technological advances to diagnose, treat, and manage various conditions effectively. Unfortunately, it appears that a lack of...
Prescription digital therapeutics (PDTs) allow patients and prescribers to work collaboratively and to use ongoing technological advances to diagnose, treat, and manage various conditions effectively. Unfortunately, it appears that a lack of...
Prescription digital...
12/14/2023
First Report Managed Care
Commentary
11/28/2023
Prescription digital therapeutics offer the potential to improve adherence and clinical outcomes while decreasing direct and indirect costs, addressing gaps in care, and enabling patients to take an active role in their care.
Prescription digital therapeutics offer the potential to improve adherence and clinical outcomes while decreasing direct and indirect costs, addressing gaps in care, and enabling patients to take an active role in their care.
Prescription digital...
11/28/2023
First Report Managed Care
Commentary
11/09/2023
As the number of PDTs continues to enter the market, it is important that clinicians and patients are aware of the regulatory processes instituted by the FDA to ensure the efficacy and safety of PDTs, and knowledge about the meticulous and...
As the number of PDTs continues to enter the market, it is important that clinicians and patients are aware of the regulatory processes instituted by the FDA to ensure the efficacy and safety of PDTs, and knowledge about the meticulous and...
As the number of PDTs continues...
11/09/2023
First Report Managed Care
10/13/2023
Otsuka's Coverage Expectations Survey results regarding payer perspectives on prescription digital therapeutics (PDT) coverage revealed that payers recognize the potential value of PDTs while highlighting the need for clarity in FDA...
Otsuka's Coverage Expectations Survey results regarding payer perspectives on prescription digital therapeutics (PDT) coverage revealed that payers recognize the potential value of PDTs while highlighting the need for clarity in FDA...
Otsuka's Coverage Expectations...
10/13/2023
First Report Managed Care
Commentary
10/11/2023
PDTs have the potential to provide an additional tool to foster a patient-centered approach to managing diabetes while also making the patient an active partner in their day-to-day care, which in turn can improve glycemic control and reduce...
PDTs have the potential to provide an additional tool to foster a patient-centered approach to managing diabetes while also making the patient an active partner in their day-to-day care, which in turn can improve glycemic control and reduce...
PDTs have the potential to...
10/11/2023
First Report Managed Care
Pharm
Commentary
09/22/2023
While the number of prescription digital therapeutics (PDTs) continues to expand as possible treatments or adjunctive treatments for the management and prevention of various medical conditions, the degree of knowledge about the availability...
While the number of prescription digital therapeutics (PDTs) continues to expand as possible treatments or adjunctive treatments for the management and prevention of various medical conditions, the degree of knowledge about the availability...
While the number of prescription...
09/22/2023
First Report Managed Care
Pharm
Commentary
09/22/2023
As the number of prescription digital therapeutics (PDTs) expands, health care providers and patients are still largely unaware of their availability and potential benefits, highlighting the need for increased awareness and education...
As the number of prescription digital therapeutics (PDTs) expands, health care providers and patients are still largely unaware of their availability and potential benefits, highlighting the need for increased awareness and education...
As the number of prescription...
09/22/2023
First Report Managed Care